Double knockdown of alpha 1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC
Background Antibody-dependent cellular cytotoxicity (ADCC) is greatly enhanced by the absence of the core fucose of oligosaccharides attached to the Fc, and is closely related to the clinical efficacy of anticancer activity in humans in vivo. Unfortunately, all licensed therapeutic antibodies and al...
Saved in:
Published in | BMC biotechnology Vol. 7; p. 84 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
30.11.2007
|
Online Access | Get full text |
Cover
Loading…
Abstract | Background Antibody-dependent cellular cytotoxicity (ADCC) is greatly enhanced by the absence of the core fucose of oligosaccharides attached to the Fc, and is closely related to the clinical efficacy of anticancer activity in humans in vivo. Unfortunately, all licensed therapeutic antibodies and almost all currently-developed therapeutic antibodies are heavily fucosylated and fail to optimize ADCC, which leads to a large dose requirement at a very high cost for the administration of antibody therapy to cancer patients. In this study, we explored the possibility of converting already-established antibody-producing cells to cells that produce antibodies fully lacking core fucosylation in order to facilitate the rapid development of next-generation therapeutic antibodies. Results Firstly, loss-of-function analyses using small interfering RNAs (siRNAs) against the three key genes involved in oligosaccharide fucose modification, i.e. alpha 1,6-fucosyltransferase (FUT8), GDP-mannose 4,6-dehydratase (GMD), and GDP-fucose transporter (GFT), revealed that single-gene knockdown of each target was insufficient to completely defucosylate the products in antibody-producing cells, even though the most effective siRNA (>90% depression of the target mRNA) was employed. Interestingly, beyond our expectations, synergistic effects of FUT8 and GMD siRNAs on the reduction in fucosylation were observed, but not when these were used in combination with GFT siRNA. Secondly, we successfully developed an effective short hairpin siRNA tandem expression vector that facilitated the double knockdown of FUT8 and GMD, and we converted antibody-producing Chinese hamster ovary (CHO) cells to fully non-fucosylated antibody producers within two months, and with high converting frequency. Finally, the stable manufacture of fully non-fucosylated antibodies with enhanced ADCC was confirmed using the converted cells in serum-free fed-batch culture. Conclusion Our results suggest that FUT8 and GMD collaborate synergistically in the process of intracellular oligosaccharide fucosylation. We also demonstrated that double knockdown of FUT8 and GMD in antibody-producing cells could serve as a new strategy for producing next-generation therapeutic antibodies fully lacking core fucosylation and with enhanced ADCC. This approach offers tremendous cost- and time-sparing advantages for the development of next-generation therapeutic antibodies. |
---|---|
AbstractList | Background Antibody-dependent cellular cytotoxicity (ADCC) is greatly enhanced by the absence of the core fucose of oligosaccharides attached to the Fc, and is closely related to the clinical efficacy of anticancer activity in humans in vivo. Unfortunately, all licensed therapeutic antibodies and almost all currently-developed therapeutic antibodies are heavily fucosylated and fail to optimize ADCC, which leads to a large dose requirement at a very high cost for the administration of antibody therapy to cancer patients. In this study, we explored the possibility of converting already-established antibody-producing cells to cells that produce antibodies fully lacking core fucosylation in order to facilitate the rapid development of next-generation therapeutic antibodies. Results Firstly, loss-of-function analyses using small interfering RNAs (siRNAs) against the three key genes involved in oligosaccharide fucose modification, i.e. alpha 1,6-fucosyltransferase (FUT8), GDP-mannose 4,6-dehydratase (GMD), and GDP-fucose transporter (GFT), revealed that single-gene knockdown of each target was insufficient to completely defucosylate the products in antibody-producing cells, even though the most effective siRNA (>90% depression of the target mRNA) was employed. Interestingly, beyond our expectations, synergistic effects of FUT8 and GMD siRNAs on the reduction in fucosylation were observed, but not when these were used in combination with GFT siRNA. Secondly, we successfully developed an effective short hairpin siRNA tandem expression vector that facilitated the double knockdown of FUT8 and GMD, and we converted antibody-producing Chinese hamster ovary (CHO) cells to fully non-fucosylated antibody producers within two months, and with high converting frequency. Finally, the stable manufacture of fully non-fucosylated antibodies with enhanced ADCC was confirmed using the converted cells in serum-free fed-batch culture. Conclusion Our results suggest that FUT8 and GMD collaborate synergistically in the process of intracellular oligosaccharide fucosylation. We also demonstrated that double knockdown of FUT8 and GMD in antibody-producing cells could serve as a new strategy for producing next-generation therapeutic antibodies fully lacking core fucosylation and with enhanced ADCC. This approach offers tremendous cost- and time-sparing advantages for the development of next-generation therapeutic antibodies. |
Author | Wakitani, Masako Iida, Shigeru Shitara, Kenya Satoh, Mitsuo Inoue, Miho Imai-Nishiya, Harue Mori, Katsuhiro |
Author_xml | – sequence: 1 givenname: Harue surname: Imai-Nishiya fullname: Imai-Nishiya, Harue – sequence: 2 givenname: Katsuhiro surname: Mori fullname: Mori, Katsuhiro – sequence: 3 givenname: Miho surname: Inoue fullname: Inoue, Miho – sequence: 4 givenname: Masako surname: Wakitani fullname: Wakitani, Masako – sequence: 5 givenname: Shigeru surname: Iida fullname: Iida, Shigeru – sequence: 6 givenname: Kenya surname: Shitara fullname: Shitara, Kenya – sequence: 7 givenname: Mitsuo surname: Satoh fullname: Satoh, Mitsuo |
BookMark | eNpNj0tPwzAQhC0EEhS4ct4TAgmDnYftckMtFCQQHOBcOX40gdQusaMq_5Sfg8tLnHY1-2l2ZoS2nXcGoSNKzikV7IIWPMOMlwRzLIottPcnbP_bd9EohFdCKBeE7aGPqe-r1sCb8-pN-7UDb0G2q1oCPWPY9sqHoY2ddMGaTgYDJzcvz-IUpNMwmz7hpXTOJ7lItDb1oDsZv7DZw_QUGpfA2FReD3jVed2rxi1AmbYNlyDBmTWEZB7NYgDrO1gYl77EDWT7th0gdfwNkSgNsU73leljo36dGxNg3cQajKulUwm6mk4mB2jHyjaYw5-5j15urp8nt_j-cXY3ubrHK0pZxHlZkjyj2VhmWgmekVIwWdlKFtYyWfCqHI8JZ6rS-ZhalhMquVA00SITiuf5Pjr-9k313nsT4nzZhE1B6YzvwzwjeUlIWeafJbuDeA |
ContentType | Journal Article |
DBID | 7QO 7T5 8FD FR3 H94 P64 |
DOI | 10.1186/1472-6750-7-84 |
DatabaseName | Biotechnology Research Abstracts Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts |
DatabaseTitle | AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1472-6750 |
EndPage | 84 |
GroupedDBID | --- -A0 0R~ 23N 2VQ 2WC 4.4 53G 5GY 5VS 6J9 7QO 7T5 8FD A8Z AAFWJ AAHBH AAJSJ ABDBF ACGFO ACGFS ACIHN ACIWK ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFGXO AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BFQNJ BMC C1A C24 C6C CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESTFP ESX F5P FR3 GROUPED_DOAJ GX1 H94 HH5 HYE I-F IAG IAO IHR INH INR IOV IPNFZ ISR ITC ITG ITH KPI KQ8 M48 ML0 M~E O5R O5S OK1 P2P P64 PGMZT RBZ RIG RNS ROL RPM RSV RVI SCM SOJ SV3 TR2 TUS W2D WOQ WOW XSB |
ID | FETCH-LOGICAL-p116t-355032129a2dc8720586abfba4ff6a47b599076cbd391f6301a78c1a2d828c733 |
IEDL.DBID | M48 |
ISSN | 1472-6750 |
IngestDate | Fri Aug 16 05:48:41 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-p116t-355032129a2dc8720586abfba4ff6a47b599076cbd391f6301a78c1a2d828c733 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 20350055 |
PQPubID | 23462 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_20350055 |
PublicationCentury | 2000 |
PublicationDate | 2007-11-30 |
PublicationDateYYYYMMDD | 2007-11-30 |
PublicationDate_xml | – month: 11 year: 2007 text: 2007-11-30 day: 30 |
PublicationDecade | 2000 |
PublicationTitle | BMC biotechnology |
PublicationYear | 2007 |
SSID | ssj0017806 |
Score | 2.244647 |
Snippet | Background Antibody-dependent cellular cytotoxicity (ADCC) is greatly enhanced by the absence of the core fucose of oligosaccharides attached to the Fc, and is... |
SourceID | proquest |
SourceType | Aggregation Database |
StartPage | 84 |
Title | Double knockdown of alpha 1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC |
URI | https://search.proquest.com/docview/20350055 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT9wwELYoXOihanmotBTmwAEkTJPYcbKVUAW7LAhpEUKshHpBfgJi68BukJp_ys_p2JsVSFTqJYfoS-xkPJ5vxuMxIVvGyFAiBDVNoxh4luRUamYoSyTa145QuQ2hgcGZOBny06v86iX_qf2Bk3-6duE8qeF4tPfnsfmJCr8fFb4U31NeZBQbTChOuPwdWcg442G0D_jLikJRJtOdRi22LeD49vk3k3K0NP2P5ENLEeFgKtNPZM76JfL-VeHAZfKMvFeNLNx7nM4MOtJQOYjbZiHdFdSFNPRmVEdSasdoqGC7P7wsd0B6A8e9c_pbel_hbY5oY28bgwMhwo4HvR248wis71RlGvoQS8JiqxBi_JMfIAGZOEymVW0bQNILN7F2dUighhDOb8BXftYJRBl4tctr9mb00CEEgcH625iFAAe9bneFDPtHl90T2p7RQB_SVNQU6UrC0Px1ZGZ0WaCsSyGVU5I7JyQvVI7mrhBaGdZJncDpRBalThGNrp4uGFsl89gn-zkkWSE30kYUQii0kqlyeamlQ0xHu5KxNbI5E8w16kD4aOlt9TS5zsLyaJLnX_6L-EoWY3A21m5cJ_P1-Ml-Q1ZRq43ojW_EQYPXi8NffwHbt86G |
link.rule.ids | 315,786,790,870,24346,27955,27956 |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Double+knockdown+of+alpha+1%2C6-fucosyltransferase+%28FUT8%29+and+GDP-mannose+4%2C6-dehydratase+%28GMD%29+in+antibody-producing+cells%3A+a+new+strategy+for+generating+fully+non-fucosylated+therapeutic+antibodies+with+enhanced+ADCC&rft.jtitle=BMC+biotechnology&rft.au=Imai-Nishiya%2C+Harue&rft.au=Mori%2C+Katsuhiro&rft.au=Inoue%2C+Miho&rft.au=Wakitani%2C+Masako&rft.date=2007-11-30&rft.issn=1472-6750&rft.eissn=1472-6750&rft.volume=7&rft.spage=84&rft.epage=84&rft_id=info:doi/10.1186%2F1472-6750-7-84&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6750&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6750&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6750&client=summon |